Immediate Implementation Of Packaged Commodity Rules desired by the Indian Medical Device Manufacturers

To ensure the product quality and the protection of the consumers’ interest, the Association of Indian Medical Device Industry (AiMeD) seeking immediate implementation of the Packaged Commodity Rules. Indian Medical Device Manufacturers are not happy with the extension of the deadline for implementation of Legal Metrology (Packaged Commodities) Amendment Rules till July and seeking implementation without any delay.

Legal Metrology amended and with new changes and now it is going to regulate pre-packaged commodities and make things compulsory for manufacturers/packers/importers to make declarations about the country of origin, date of manufacture, quantity, expiry date among other details of the product. It was pending to be implemented from January 1st,2018 and then was extended up to the end of January 2018 following the representations from manufacturers/ packers/importers. And the department of consumer affairs further relaxed the deadline till February, then April this year. But now the April deadline has now been extended till the end of July 2018. The deadline keeps on extending and now the Association of Indian Medical Device Industry (AiMeD) want no more delay in its implementation.

Newly revised rules, mandates manufacturers to increase the font size of product details, so buyers/consumers can read them easily. Barcoding product details, although voluntary, has also been mentioned in the new rules. To give an appropriate time of implementation, the Indian government has mentioned clearly that in the starting months of implementation of the new rules, no one will be prosecuted for failing to comply with labeling requirements.

Rajiv Nath, Forum Coordinator of AiMeD said while welcoming the Legal Metrology Rules that these rules aimed to safeguard consumers. Indian medical device manufacturers are ready to comply with the rules and want no more delay in its implementation. Rajiv Nath also shared they request to make rules that comply with the level playing field of the foreign manufacturers and Indian manufacturers. It’s obvious that the rules should be further amended to ensure that substandard devices should be checked at point of entry into the country i.e. ports and not retail counters as many of these medical devices are billed to consumers by hospitals and not sold over a retail counter.

These amendments will protect consumers and domestic Indian industry which is reeling under the import of substandard low priced imports. There are instances of Chinese imports being claimed to be ‘Made in India’ medical devices. 80 percent of medical devices’ requirement is fulfilled through imports around and a fourth of that comes from the US. The overall medical devices market in the country is estimated to be Rs.640 billion.

It is learned that MNC medical device manufacturers have expressed reservation over an increase in the font size of product details on packs as it is not affecting consumers in any way. They also sought clarity over the declaration of country of origin on the packs. For instance, a manufacturer sourcing certain parts of the product from country A and assembling and packaging them in country B has found it difficult to comply with a provision of amended rules related to declaration of country of origin on the product pack, said a patent lawyer handling MNCs on condition of anonymity.

Related Posts

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

AiMeD welcomes, also offering help design a Uniform National Framework for Holistic Transparency New Delhi/ Bangalore: Central government and Karnataka government have initiated measures to bring about greater transparency in…

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

NEW DELHI: Medical technology innovation is entering a new phase, with advanced cardiac implants, incisionless brain surgery, blood-based cancer screening, smart insulin delivery and real-time kidney-function monitoring among the technologies…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

Three arrested after liquor bottles found at pharma firm

Three arrested after liquor bottles found at pharma firm

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day